79423293 - SIFTAXYS

Information

  • Trademark
  • 79423293
  • Serial Number
    79423293
  • Filing Date
    March 21, 2025
    7 months ago
  • Transaction Date
    June 22, 2025
    4 months ago
  • Status Date
    June 20, 2025
    4 months ago
  • Location Date
    June 20, 2025
    4 months ago
  • Status Code
    640
  • Current Location
    TMO LAW OFFICE 112
    Employee Name
    GLUECK, CHRISTOPHER
  • Law Office Assigned Location Code
    M30
  • Owners
Mark Drawing Code
4
Mark Identification
SIFTAXYS
Case File Statements
  • GS0051: Pharmaceutical and biopharmaceutical products and preparations for the medical treatment of gastrointestinal diseases and disorders emanating from microbiota dysfunction; pharmaceutical and biopharmaceutical products and preparations used for the treatment of cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; pharmaceuticals used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases.
  • GS0101: Medical and surgical apparatus and instruments; drug delivery devices, including medical apparatus and instruments for administration of pharmaceutical and biopharmaceutical products and preparations; drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, in the nature of a kit comprising a prefilled suspension bag and administration tube set.
Case File Event Statements
  • 5/8/2025 - 5 months ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 5/12/2025 - 5 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/12/2025 - 5 months ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 6/18/2025 - 4 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/21/2025 - 4 months ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 6/20/2025 - 4 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT